Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 5.84
1.21 %
$ 216 M
Market Cap
-10.43
P/E
Price Target
Average
11.30%
Revenue Forecast
Estimate
10.58%
EBIT
Estimate
--41.99%
Net Income
Estimate
--52.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lifecore Biomedical, Inc.
Wall Street analysts predict an average 1-year price target for LFCR of $6.5 , with forecasts ranging from
a
low of
$5 to a high of $8 .
LFCR Lowest Price Target
Wall Street Target
5 USD
-14.38%
LFCR Average Price Target
Wall Street Target
6.5 USD
11.30%
LFCR Highest Price Target
Wall Street Target
8 USD
36.99%
REVENUE FORECAST
Revenue Forecast Chart LFCR
EBIT FORECAST
EBIT Forecast Chart LFCR
NET INCOME FORECAST
Net Income Chart LFCR